Abstract
Objective To investigate correlation between levels of serum relaxin and coronary atherosclerotic heart disease. Methods Two hundred and thirty-three patients were recruited from February 2015 to April 2016, 91 cases in acute coronary syndrome(ACS) group, 72 cases in stable angina pectoris(SAP) group and 70 cases in normal control(NC) group. Enzyme linked immunosorbent assay(ELISA) was used to measure the levels of serum relaxin, and the correlation between the levels of serum relaxin and other risk factors of coronary atherosclerotic heart disease was analyzed. Results The plasma relaxin level in ACS group was(29.31±7.14) ng/ml, that in SAP group was(12.01±4.10)ng/ml, that in NC group was(5.78±3.11)ng/ml, the differences were significant(P<0.05). The plasma relaxin level was positively correlated with age, diabetes mellitus, hypertension, smoking history and level of high density lipoprotein. Conclusions Serum relaxin is a new marker of coronary heart disease, which may be a new risk factor for coronary heart disease. Key words: Coronary heart disease; Acute coronary syndrome; Stable angina pectoris; Relaxin
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
